Skip to main content
Premium Trial:

Request an Annual Quote

Healthcare Firm Taps Instem's Products to Support Drug R&D Efforts

Premium

Instem said this week, than an undisclosed healthcare company has licensed its Centrus software suite and SRS platform to support ongoing drug research and development efforts.

The Centrus suite provides users with a single, secure environment to access, harmonize, and use early drug development information from a variety of sources, including data acquisition systems, warehouses, as well as partner and contract research applications. The suite includes Centrus submit, which lets users convert data into the Standard for Exchange of Non-Clinical Data, or SEND, format — a standard developed by the Clinical Data Interchange Standards Consortium for non-clinical data collected from animal toxicology studies.

Instem said its new customer has also licensed SRS, its genomic data integration platform, to help researchers access, integrate, and query SEND data being created from their own preclinical data collection system as well as SEND data received from their external study partners.

The financial details of the agreement are not being disclosed.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more